Cargando…

Success for gene therapy: render unto Caesar that which is Caesar's

Reports that two young children developed leukemia after being treated for immunodeficiency with their own retrovirally modified bone-marrow cells delivered a severe blow to confidence in gene therapy as a treatment. Two reports, published since the trial was initiated, now take away some of the mys...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Jian, Diaz, Rosa Maria, Vile, Richard G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC507871/
https://www.ncbi.nlm.nih.gov/pubmed/15287968
http://dx.doi.org/10.1186/gb-2004-5-8-237
_version_ 1782121686385033216
author Qiao, Jian
Diaz, Rosa Maria
Vile, Richard G
author_facet Qiao, Jian
Diaz, Rosa Maria
Vile, Richard G
author_sort Qiao, Jian
collection PubMed
description Reports that two young children developed leukemia after being treated for immunodeficiency with their own retrovirally modified bone-marrow cells delivered a severe blow to confidence in gene therapy as a treatment. Two reports, published since the trial was initiated, now take away some of the mystery as to why these events happened and allay fears for the safety of gene therapy across all therapeutic applications.
format Text
id pubmed-507871
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-5078712004-08-10 Success for gene therapy: render unto Caesar that which is Caesar's Qiao, Jian Diaz, Rosa Maria Vile, Richard G Genome Biol Minireview Reports that two young children developed leukemia after being treated for immunodeficiency with their own retrovirally modified bone-marrow cells delivered a severe blow to confidence in gene therapy as a treatment. Two reports, published since the trial was initiated, now take away some of the mystery as to why these events happened and allay fears for the safety of gene therapy across all therapeutic applications. BioMed Central 2004 2004-07-29 /pmc/articles/PMC507871/ /pubmed/15287968 http://dx.doi.org/10.1186/gb-2004-5-8-237 Text en Copyright © 2004 BioMed Central Ltd
spellingShingle Minireview
Qiao, Jian
Diaz, Rosa Maria
Vile, Richard G
Success for gene therapy: render unto Caesar that which is Caesar's
title Success for gene therapy: render unto Caesar that which is Caesar's
title_full Success for gene therapy: render unto Caesar that which is Caesar's
title_fullStr Success for gene therapy: render unto Caesar that which is Caesar's
title_full_unstemmed Success for gene therapy: render unto Caesar that which is Caesar's
title_short Success for gene therapy: render unto Caesar that which is Caesar's
title_sort success for gene therapy: render unto caesar that which is caesar's
topic Minireview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC507871/
https://www.ncbi.nlm.nih.gov/pubmed/15287968
http://dx.doi.org/10.1186/gb-2004-5-8-237
work_keys_str_mv AT qiaojian successforgenetherapyrenderuntocaesarthatwhichiscaesars
AT diazrosamaria successforgenetherapyrenderuntocaesarthatwhichiscaesars
AT vilerichardg successforgenetherapyrenderuntocaesarthatwhichiscaesars